Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation
THE SO WHAT
When a Crispr pioneer questions AI’s ability to replace human-driven discovery, it reinforces that wet-lab validation and domain intuition remain the gating factors in biotech. Healthtech teams should frame AI as an accelerator for hypothesis generation and experiment design — not a substitute for experimental cycles or regulatory-grade evidence.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIPentagon Sees Broader Role for AI in Setting Military Targets
The Pentagon quietly revising doctrine to let AI play a larger role in target selection means AI decision systems are crossing into domains where error is existential, not just costly. Any team building high-stakes AI — in defense, finance, or healthcare — should assume regulators will borrow this playbook and demand doctrine-level governance, not just model cards.
Applied AISources: Sam Altman told staff the US government asked OpenAI to stagger the release of GPT 5.6 over security concerns, approving "access customer by customer"
If the US government is vetting GPT‑5.6 access customer by customer, frontier models are now effectively a regulated dual-use export. Enterprises should assume that access to top-tier capabilities may be gated by sector, geography, and use case — and design fallbacks on less sensitive models.
Applied AIDuckDuckGo, Unable to Resist the Pull of AI, Mistakenly Claims Trump Died of Rabies
Search vendors that built their brand on trust are now discovering that bolting on generative answers creates a new failure mode—confident, reputationally toxic hallucinations. If you operate any consumer-facing AI surface, you need explicit policies and kill switches for high-sensitivity entities and claims, not just better models.
Applied AIPatronus AI lands $50M to build ‘digital worlds’ that stress-test AI agents
A $50M round for synthetic “digital worlds” is a bet that agentic AI will need its own equivalent of crash-test facilities before enterprises trust it with workflows. If you’re building or buying agents, start budgeting for eval and simulation tooling as a first-class line item, not an afterthought.